The Business of Medicine
Beyond the doctor's office are a group of Greater New Orleans companies that are dedicated to developing tangible support to fighting neurodegenerative disease for patients around ths world.
The products and services that are provided allow healthcare workers to achieve better results on behalf of their patients, and allow those receiving care to thrive.
AxoSim
Empowering advancements in human neuroscience drug discovery.
AxoSim is a biotechnology company that foster innovation and facilitate breakthroughs in the treatment of the world’s most devastating neurodegenerative diseases through partnerships with pharmaceutical and biotechnology companies.
Research Assets
- NerveSim® and BrainSim® deliver clinically relevant data to assist drug discovery and developmental efforts by aiming to reduce drug clinical failure rates allowing for more efficient and effective drug to be brought to market.
- To predict drug neurotoxicity and human efficacy at earliest stages in drug development pipeline, AxoSim offers validated tissue models of the PNS with their NerveSim® and CNS with their BrainSim®
- AxoSim’s NerveSim® technology is the only in vitro model with human-relevant electrophysiology and structural biology
Pine Biotech
Pine Biotech offers data analysis solutions to capture complex associations between molecular, clinical and phenotypic features found in multi-omics data
Pine Biotech's data analysis platform, is used by various research groups to analyze, manage and integrate big data that helps simplify complex analytical approaches to extract meaningful insights. In addition, Pine BioTech has developed a system for animal model phenotyping which provides insights into behavioral and long-term physiological changes through multi-sensor tracking. Using these resources, researchers can study genomic, transcriptomic, epigenomic and metagenomic data across organoids, animal models and patients to understand molecular determinants of pathology, uncover biomarkers and identify actionable targets.
Research Assets
- Simplifying bioinformatics and advance research through modular and intuitive multi-omics analysis platform
Additional Assets
- Deep phenotyping for pre-clinical animal models